- Filed
- Aug 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jun 30, 2024 | 58.08M sh |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $84.58K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $57.7K |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $84.58K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $57.7K |
| Current Assets | Q2 2024 · Jun 30, 2024 | $0 |
| Current Assets | Q2 2024 · Dec 31, 2023 | $0 |
| Total Assets | Q2 2024 · Jun 30, 2024 | $0 |
| Total Assets | Q2 2024 · Dec 31, 2023 | $0 |
| Net Income | Q2 2024 · Mar 31, 2024 | −$6.55K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$2.47K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$36.19K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$33.72K |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 58.08M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 58.05M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $0 |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$36.19K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $637 |
| Cash And Equivalents | Q2 2024 · Dec 31, 2022 | $754 |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | −$44.96K |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$42.48K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$8.77K |
| Stockholders Equity | Q2 2024 · Dec 31, 2003 | −$57.7K |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$0.00 |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$2.47K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$36.19K |
| Revenue | Q2 2024 · Jun 30, 2023 | $0 |
| Revenue | Q2 2024 · Jun 30, 2023 | $0 |